Gary S. Gillheeney, President and CEO at Organogenesis Holdings Inc. (ORGO), sold 460,139 shares at $3.64 ($1.7M) on 2024-12-11, disclosed to the SEC on 2024-12-12.
Open-market sale of $1.7M ORGO by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.64 | 58,525 | $213K | 12.8% |
| 2 | $3.64 | 157,448 | $573K | 34.4% |
| 3 | $3.64 | 157,448 | $573K | 34.4% |
| 4 | $3.55 | 43,359 | $154K | 9.2% |
| 5 | $3.55 | 43,359 | $154K | 9.2% |
| Total | $3.62 avg | 460,139 |
| $1.7M |
| 100% |
| Filing → |
| ORGO | SELL | 2022-06-03 | $2.7M | — | Filing → |
| ORGO | SELL | 2022-05-31 | $2.6M | — | Filing → |
| ORGO | SELL | 2022-05-25 | $1.9M | — | Filing → |